投資有価証券売却益、Impairment LossEL - Chemistry Reportable Segments Member、Minority Interests他2件
- 【期間】
| 年度 | 投資有価証券売却益 | Impairment LossEL - Chemistry Reportable Segments Member | Minority Interests | Retirement Benefit LiabilityNCLIFRS | 四半期包括利益合計 |
|---|
| 2010/12 | - | | - | | - | | - | | - | |
| 2011/12 | - | | - | | - | | - | | - | |
| 2012/12 | - | | - | | - | | - | | - | |
| 2013/12 | 446億 | | - | | - | | - | | - | |
| 2014/12 | 61.4億 | -86.2% | - | | - | | - | | - | |
| 2015/12 | - | | - | | - | | - | | - | |
| 2016/12 | - | | - | | - | | - | | - | |
| 2017/12 | 246億 | +300.3% | - | | - | | - | | - | |
| 2018/12 | 303億 | +23.5% | - | | - | | - | | 409億 | |
| 2019/12 | - | | - | | - | | - | | -3614億 | 赤転 |
| 2020/12 | - | | - | | - | | - | | -720億 | 赤縮 |
| 2021/12 | - | | - | | - | | - | | 6179億 | 黒転 |
| 2022/12 | - | | - | | - | | - | | 8081億 | +30.8% |
| 2023/12 | - | | - | | - | | - | | 7105億 | -12.1% |
